Search Results - "Beaufort, A M"

Early reversal of profound rocuronium-induced neuromuscular blockade by sugammadex in a randomized multicenter study : Efficacy, safety, and pharmacokinetics by SPARR, Harald J, VERMEYEN, Karel M, BEAUFORT, Anton M, RIETBERGEN, Henk, PROOST, Johannes H, SALDIEN, Vera, VELIK-SALCHNER, Corinna, WIERDA, J. Mark K. H

“…Sugammadex reverses the neuromuscular blocking effects of rocuronium by chemical encapsulation. The efficacy, safety, and pharmacokinetics of sugammadex for…”
Get full text

Preliminary investigations of the clinical pharmacology of three short-acting non-depolarizing neuromuscular blocking agents, Org 9453, Org 9489 and Org 9487 by WIERDA, J. M. K. H, BEAUFORT, A. M, KLEEF, U. W, SMEULERS, N. J, AGOSTON, S

“…Three muscle relaxants, Org 9453, Org 9489 and Org 9487, short-acting in animals, were investigated to establish their profiles in humans. Potency, time course…”
Get full text

The influence of hypothermia (surface cooling) on the time-course of action and on the pharmacokinetics of rocuronium in humans by Beaufort, A M, Wierda, J M, Belopavlovic, M, Nederveen, P J, Kleef, U W, Agoston, S

“…Hypothermia prolongs the time-course of action of non-depolarizing neuromuscular blocking agents. The mechanism, however, is unknown. We studied the influence…”
Get more information

Innervator NS 252, a new, constant current and programmable peripheral nerve stimulator by Beaufort, A M, Rowaan, C J, Wierda, J M

“…A peripheral nerve stimulator should be able to deliver a constant current to provide supramaximal nerve stimulation even under conditions of increasing…”
Get more information

The isolated heart-lung preparation in the cat. An in situ model to study the role of the lungs in the disposition of drugs by Beaufort, A M, Wierda, J M, Houwertjes, M C, Kleef, U W, Meijer, D K

“…In the search for drugs with an extreme short time course of action, compounds should be developed that are rapidly distributed to and temporarily stored in…”
Get more information

Reversal of rocuronium induced neuromuscular block by Org 25969: pharmacokinetics: A-576 by Vermeyen, K. M., Sparr, H. J., Beaufort, A. M., Houwing, N. S., Saldien, V., Velik-Salchner, C., Wierda, J. M.K.H.

Get full text

How Best to Define the Concept of Minimal Risk by Westra, Anna E., MA, MD, Wit, Jan M., MD, PhD, Sukhai, Rám N., MD, PhD, de Beaufort, Inez D., MA, PhD

Get full text

Standards of various national societies and their actual use in practice by Wilhelm, W, Khuenl-Brady, K, Beaufort, A M, Tassonyi, E, Meistelman, C

Get full text

Vorgaben verschiedener nationaler Fachgesellschaften und deren Umsetzung in die Praxis: Neuromuskuläres Monitoring by WILHELM, W, KHUENL-BRADY, K, BEAUFORT, A. M, TASSONYI, E, MEISTELMAN, C

Get full text